8-K
filed June 4, 2026, 4:11 PM ET
ticker GMED
CIK 0001237831
other material
confidence high
sentiment neutral
materiality 0.25
Globus Medical shareholders approve 1M share increase to equity plan, re-elect directors
GLOBUS MEDICAL INC
- Stockholders approved amendment to 2021 Equity Incentive Plan, increasing authorized shares by 1,000,000 to 12,000,000.
- Keith Pfeil and Robert A. Douglas re-elected as Class II directors with substantial majority support.
- Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2026.
- Non-binding advisory vote on 2025 executive compensation passed with 316M for vs. 5.2M against.
- No other matters were submitted to stockholders at the June 3, 2026 Annual Meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
GLOBUS MEDICAL INC shareholders approved Approval of 2021 Equity Incentive Plan Amendment.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
The Company’s stockholders approved the 2021 Equity Incentive Plan Amendment.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
GLOBUS MEDICAL INC shareholders approved Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company’s named executive officers.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
The Company’s stockholders approved, on a non-binding, advisory basis the 2025 compensation of the Company’s named executive officers, as described in the Proxy Statement.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
GLOBUS MEDICAL INC shareholders approved Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Each of the director nominees listed below were elected by the Company’s stockholders at the Annual Meeting to serve a three-year term on the Board.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
GLOBUS MEDICAL INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-12-31
Exact text from the filing
The Company’s stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.